Ibrutinib Is a Newly Recognized Host Factor for the Definition of Probable Invasive Pulmonary Mold Disease, Based on Off-target Effects, Unrelated to Its B-cell Immunosuppressant Activity Reply

Authors :: Wingard, John R
Maertens, Johan
Pagano, Livio
Chen, Sharon C-A
Pappas, Peter G
Donnelly, J Peter
Publication Year :: 2020
Publisher :: OXFORD UNIV PRESS INC, 2020.
Abstract: ispartof: CLINICAL INFECTIOUS DISEASES vol:71 issue:12 pages:3266-3266 ispartof: location:United States status: published

Subjects :: Science & Technology
Infectious Diseases
Immunology
TYROSINE KINASE
Life Sciences & Biomedicine
Microbiology
THERAPY

Tools